<DOC>
	<DOCNO>NCT01738841</DOCNO>
	<brief_summary>This study collect data safety MMRV vaccine ( Priorix-Tetra™ ) use routine practice child age 12 month 12 year live Philippines .</brief_summary>
	<brief_title>Safety Study Measles-Mumps-Rubella-Varicella ( MMRV ) Vaccine , Priorix-Tetra™ Children Living Philippines</brief_title>
	<detailed_description>The participate physician enroll subject would prescribe Priorix-Tetra course normal clinical practice .</detailed_description>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Mumps</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<criteria>Subjects investigator believe parent ( ) /Legally Acceptable Representative ( ) [ LAR ( ) ] comply requirement protocol . Written inform consent obtain parent ( ) /LAR ( ) subject . Male female subject live Philippines , include , age 12 month 12 year time vaccination . Female subject child bear potential may enrol study , subject : agree abstinent practice adequate contraception 30 day prior vaccination , negative pregnancy test day vaccination , agree continue adequate contraception entire treatment period 3 month completion vaccination . Child care . Any contraindication vaccination state Prescribing Information . Acute , severe febrile illness time enrollment . The presence minor infection , cold , exclude subject study . Previous receipt measles , mumps , rubella and/or varicellavirus contain vaccine le 3 month prior study entry . Previous enrolment trial . Subjects impair immune function , include primary secondary immunodeficiency base medical history . History hypersensitivity component vaccine . History hypersensitivity follow previous administration measles , mumps , rubella and/or varicellavirus contain vaccine . Receipt human gamma globulin blood transfusion within 3 month prior study entry . Hypersensitivity latex . Pregnant lactate female .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Combined measles-mumps-rubella-varicella vaccine</keyword>
	<keyword>Priorix-Tetra™</keyword>
	<keyword>MMRV</keyword>
	<keyword>child</keyword>
	<keyword>Post-marketing surveillance</keyword>
	<keyword>Philippines</keyword>
</DOC>